|
TNPO3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01430000013048E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168500E-04 |
| Normal-vs-Stage2 |
8.48509999999969E-05 |
| Normal-vs-Stage3 |
1.84509999945348E-07 |
| Normal-vs-Stage4 |
3.294500E-02 |
| Stage1-vs-Stage2 |
1.354430E-01 |
| Stage1-vs-Stage3 |
1.266460E-02 |
| Stage1-vs-Stage4 |
9.729000E-01 |
| Stage2-vs-Stage3 |
6.918600E-01 |
| Stage2-vs-Stage4 |
2.679000E-01 |
| Stage3-vs-Stage4 |
1.207790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.68759999991708E-07 |
| Normal-vs-AfricanAmerican |
3.32209999998057E-06 |
| Normal-vs-Asian |
4.542800E-01 |
| Caucasian-vs-AfricanAmerican |
3.456100E-02 |
| Caucasian-vs-Asian |
4.172400E-02 |
| AfricanAmerican-vs-Asian |
8.222300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.38000000000127E-08 |
| Normal-vs-Female |
7.415700E-04 |
| Male-vs-Female |
1.416000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.090750E-01 |
| Normal-vs-Age(41-60Yrs) |
1.91201999999446E-05 |
| Normal-vs-Age(61-80Yrs) |
2.04719999999936E-05 |
| Normal-vs-Age(81-100Yrs) |
3.829600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.778600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.226400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.027190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.889200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.400500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.435500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.907200E-01 |
| Normal-vs-Grade 2 |
4.89250000001995E-06 |
| Normal-vs-Grade 3 |
1.81728999999464E-05 |
| Normal-vs-Grade 4 |
1.195870E-03 |
| Grade 1-vs-Grade 2 |
2.203000E-01 |
| Grade 1-vs-Grade 3 |
2.509200E-01 |
| Grade 1-vs-Grade 4 |
2.341800E-01 |
| Grade 2-vs-Grade 3 |
7.009400E-01 |
| Grade 2-vs-Grade 4 |
5.281600E-01 |
| Grade 3-vs-Grade 4 |
7.050600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.006700E-04 |
| Normal-vs-ccB subtype |
5.61239999999907E-05 |
| ccA subtype-vs-ccB subtype |
3.249400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58658999999117E-05 |
| Normal-vs-N1 |
9.823800E-01 |
| N0-vs-N1 |
3.204800E-01 |
|
|
